How Advanced Analytics And AI Are Transforming Healthcare
By Dr. Jeff R. Livingstone, Unisys Many healthcare organizations already have started to shift from the traditional fee-for-service model to a
Educational
Why is 177Lu Expected to Be So Important in Targeted Radionuclide Therapy?
The striking diffusion and exciting perspectives of 177Lu in targeted radionuclide therapy (TRT) are primarily attributed to the following. The mean penetration range of β− particles
Technetium-99m generators
Technetium-99m is a radioactive tracer that is used in twenty million medical diagnostic procedures per year. At least 31 radiopharmaceuticals based on Tc-99m are used
Actinium-225 in targeted alpha-particle therapeutic applications
Abstract Alpha particle-emitting isotopes are being investigated in radioimmunotherapeutic applications because of their unparalleled cytotoxicity when targeted to cancer and their relative lack
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.
Abstract BACKGROUND: A remarkable therapeutic efficacy has been demonstrated with 225Ac-prostate-specific membrane antigen (PSMA)-617 in heavily pre-treated metastatic castration-resistant prostate cancer (mCRPC) patients.
Technical and dosimetric aspects of iodine-125 seed reimplantation in suboptimal prostate implants
Abstract Objective: Brachytherapy employing iodine-125 seeds is an established treatment for low-risk prostate cancers. Post-implant dosimetry (PID) is an important tool for identifying suboptimal
Theranostics in nuclear medicine practice
Abstract: The importance of personalized medicine has been growing, mainly due to a more urgent need to avoid unnecessary and expensive treatments.
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
Abstract Background: This review provides a comprehensive summary of the production of 177Lu to meet expected future research and clinical demands. Availability of
Estimation of whole body radiation exposure to nuclear medicine personnel during synthesis of 177lutetium-labeled radiopharmaceuticals
Abstract Purpose of the Study: With rapid development in the field of nuclear medicine therapy, radiation safety of the personnel involved in synthesis
